Since many repeat expansion mutations, including C9-ALS, have an epigenetic component that is directly linked to pathology, our observations are of significant importance for understanding the mechanism of disease and are of consequence for therapeutic development efforts utilizing C9-BAC mouse models. Here, C9 is linked to amyotrophic lateral sclerosis.